Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Israel Rubinstein

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Expert Review of Cardiovascular Therapy|August 4, 2005
Human VIP-alpha: an emerging biologic response modifier to treat primary pulmonary hypertensionIsrael Rubinstein
Cardiovascular Drugs and Therapy|October 18, 2006
Prolonged anti-hypertensive effects of oral sitaxsentan, a selective ET(A) endothelin receptor antagonist, in spontaneoulsy hypertensive hamstersIsrael Rubinstein
Nanomedicine (London, England)|May 29, 2012
Oral insulin: déjà vu?Israel Rubinstein
American Journal of Respiratory and Critical Care Medicine|April 6, 2002
Upper airway inflammation in obstructive sleep apneaIsrael Rubinstein
Nanomedicine (London, England)|July 20, 2012
Brain nanomedicine up the noseIsrael Rubinstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 14, 2007
Bradykinin- and substance P-induced edema formation in the hamster cheek pouch is tyrosine kinase dependentIsrael Rubinstein
Nanomedicine (London, England)|July 20, 2012
Oral insulin: active targeting to the intestinal mucosaIsrael Rubinstein
Clinical and Molecular Allergy : CMA|March 17, 2004
Low-dose, long-term macrolide therapy in asthma: An overviewUmur Hatipoglu, Israel Rubinstein
Hypertension (Dallas, Tex. : 1979)|July 7, 2021
Population-Based Magnetic Resonance Imaging: Earlier Detection of Hypertensive Cerebral Small Vessel Disease?Malvika Kaul, Israel Rubinstein
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|January 2, 2014
Antidote for bromethalin poisoningIsrael Rubinstein, Guy Weinberg
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Expert Review of Cardiovascular Therapy|August 4, 2005
Human VIP-alpha: an emerging biologic response modifier to treat primary pulmonary hypertensionIsrael Rubinstein
Cardiovascular Drugs and Therapy|October 18, 2006
Prolonged anti-hypertensive effects of oral sitaxsentan, a selective ET(A) endothelin receptor antagonist, in spontaneoulsy hypertensive hamstersIsrael Rubinstein
Nanomedicine (London, England)|May 29, 2012
Oral insulin: déjà vu?Israel Rubinstein
American Journal of Respiratory and Critical Care Medicine|April 6, 2002
Upper airway inflammation in obstructive sleep apneaIsrael Rubinstein
Nanomedicine (London, England)|July 20, 2012
Brain nanomedicine up the noseIsrael Rubinstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 14, 2007
Bradykinin- and substance P-induced edema formation in the hamster cheek pouch is tyrosine kinase dependentIsrael Rubinstein
Nanomedicine (London, England)|July 20, 2012
Oral insulin: active targeting to the intestinal mucosaIsrael Rubinstein
Clinical and Molecular Allergy : CMA|March 17, 2004
Low-dose, long-term macrolide therapy in asthma: An overviewUmur Hatipoglu, Israel Rubinstein
Hypertension (Dallas, Tex. : 1979)|July 7, 2021
Population-Based Magnetic Resonance Imaging: Earlier Detection of Hypertensive Cerebral Small Vessel Disease?Malvika Kaul, Israel Rubinstein
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|January 2, 2014
Antidote for bromethalin poisoningIsrael Rubinstein, Guy Weinberg
Pageof 19